Fictional patients, real format. This is exactly how your notes will look — full SOAP, ICD-10 codes, and a clear plan.
Primary care · MOCK — fictional patient
S: 58-year-old male, follow-up for hypertension. Reports taking amlodipine 5 mg daily as prescribed. No chest pain, no shortness of breath, no headache. Home BP readings in the 130s/80s. Denies dizziness, ankle swelling, or palpitations. Diet: trying to reduce salt. Exercises by walking 30 minutes, 4 days a week.
O: BP 132/82, HR 72, RR 14, Temp 98.4°F, BMI 28.4. Lungs clear to auscultation. Heart regular rate and rhythm, no murmurs. No peripheral edema. No focal neurological deficits.
A: Hypertension, controlled on current therapy. No adverse effects from amlodipine. Overweight, counselled on weight and lifestyle.
P: Continue amlodipine 5 mg daily. Low-sodium diet, continue walking. Recheck BP in 3 months; home BP log at next visit. ICD-10: I10, E66.9.
Internal medicine · MOCK — fictional patient
S: 52-year-old female, follow-up for type 2 diabetes. Reports taking metformin 1000 mg twice daily. Fasting glucose mostly 130–160 mg/dL. No polyuria, no polydipsia, no blurred vision. Some tingling in both feet, worse at night. Denies foot wounds. Diet: trying to cut sugary drinks.
O: BP 128/78, HR 76, BMI 31.2. Feet: intact skin, no ulcers; diminished light touch sensation bilaterally. HbA1c 7.8% (last month).
A: Type 2 diabetes mellitus, above target (HbA1c 7.8%). Diabetic peripheral neuropathy, mild, bilateral. Overweight.
P: Continue metformin 1000 mg BID. Add gabapentin 300 mg at night for neuropathic pain, counselled on drowsiness. Diabetes education and dietitian referral. Foot care counselling. Recheck HbA1c in 3 months. ICD-10: E11.65, E11.42, E66.9.
Psychiatry · MOCK — fictional patient
S: 34-year-old female, follow-up for generalized anxiety disorder. Reports taking sertraline 50 mg daily for 6 weeks. Anxiety improved — "I can sleep through the night now." Still worries about work deadlines. No panic attacks since last visit. Denies suicidal thoughts, denies self-harm. PHQ-9: 6. GAD-7: 9.
O: Alert, cooperative, good eye contact. Speech normal rate and rhythm. Mood "better", affect congruent. Thought process linear, no psychosis. No safety concerns identified.
A: Generalized anxiety disorder, improving on sertraline 50 mg. Mild depressive symptoms (PHQ-9 6). No safety risk at this time.
P: Continue sertraline 50 mg daily. Continue CBT techniques and sleep hygiene. Safety plan reviewed. Follow up in 4 weeks; sooner if anxiety worsens. ICD-10: F41.1, F32.0.
These are mock notes with fictional patients, written to show format and quality. Your notes will follow your template and your style.